Follow
Roberto Salgado
Roberto Salgado
Unknown affiliation
No verified email
Title
Cited by
Cited by
Year
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
R Salgado, C Denkert, S Demaria, N Sirtaine, F Klauschen, G Pruneri, ...
Annals of oncology 26 (2), 259-271, 2015
19282015
Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition …
S Loi, N Sirtaine, F Piette, R Salgado, G Viale, F Van Eenoo, G Rouas, ...
J Clin Oncol 31 (7), 860-867, 2013
14452013
Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial
S Loi, S Michiels, R Salgado, N Sirtaine, V Jose, D Fumagalli, ...
Annals of oncology 25 (8), 1544-1550, 2014
11182014
CD4+ follicular helper T cell infiltration predicts breast cancer survival
C Gu-Trantien, S Loi, S Garaud, C Equeter, M Libin, A De Wind, M Ravoet, ...
The Journal of clinical investigation 123 (7), 2873-2892, 2013
7972013
Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis
S Turajlic, K Litchfield, H Xu, R Rosenthal, N McGranahan, JL Reading, ...
The lancet oncology 18 (8), 1009-1021, 2017
6472017
Clinical relevance of host immunity in breast cancer: from TILs to the clinic
P Savas, R Salgado, C Denkert, C Sotiriou, PK Darcy, MJ Smyth, S Loi
Nature reviews Clinical oncology 13 (4), 228-241, 2016
5982016
Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis
P Savas, B Virassamy, C Ye, A Salim, CP Mintoff, F Caramia, R Salgado, ...
Nature medicine 24 (7), 986-993, 2018
5402018
Circulating interleukin‐6 predicts survival in patients with metastatic breast cancer
R Salgado, S Junius, I Benoy, P Van Dam, P Vermeulen, E Van Marck, ...
International journal of cancer 103 (5), 642-646, 2003
5282003
Neoantigen-directed immune escape in lung cancer evolution
R Rosenthal, EL Cadieux, R Salgado, MA Bakir, DA Moore, CT Hiley, ...
Nature 567 (7749), 479-485, 2019
4892019
Tumor-infiltrating lymphocytes and associations with pathological complete response and event-free survival in HER2-positive early-stage breast cancer treated with lapatinib …
R Salgado, C Denkert, C Campbell, P Savas, P Nuciforo, C Aura, ...
JAMA oncology 1 (4), 448-455, 2015
4672015
Assessing tumor infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the International Immuno-Oncology …
S Hendry, R Salgado, T Gevaert, PA Russell, T John, B Thapa, M Christie, ...
Advances in anatomic pathology 24 (6), 311, 2017
4372017
Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial
L Voorwerk, M Slagter, HM Horlings, K Sikorska, KK van de Vijver, ...
Nature medicine 25 (6), 920-928, 2019
4122019
RAS/MAPK activation is associated with reduced tumor-infiltrating lymphocytes in triple-negative breast cancer: therapeutic cooperation between MEK and PD-1/PD-L1 immune …
S Loi, S Dushyanthen, PA Beavis, R Salgado, C Denkert, P Savas, ...
Clinical Cancer Research 22 (6), 1499-1509, 2016
4112016
Tumor-infiltrating lymphocytes and prognosis: a pooled individual patient analysis of early-stage triple-negative breast cancers
S Loi, D Drubay, S Adams, G Pruneri, PA Francis, M Lacroix-Triki, ...
Journal of clinical oncology 37 (7), 559, 2019
4082019
Assessing tumor infiltrating lymphocytes in solid tumors: A practical review for pathologists and proposal for a standardized method from the International Immuno-Oncology …
S Hendry, R Salgado, T Gevaert, PA Russell, T John, B Thapa, M Christie, ...
Advances in anatomic pathology 24 (5), 235, 2017
4062017
Increased serum interleukin-8 in patients with early and metastatic breast cancer correlates with early dissemination and survival
IH Benoy, R Salgado, P Van Dam, K Geboers, E Van Marck, S Scharpé, ...
Clinical Cancer Research 10 (21), 7157-7162, 2004
3612004
Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy
DB Johnson, MV Estrada, R Salgado, V Sanchez, DB Doxie, SR Opalenik, ...
Nature communications 7 (1), 1-10, 2016
3542016
Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in …
MV Dieci, N Radosevic-Robin, S Fineberg, G Van den Eynden, N Ternes, ...
Seminars in cancer biology 52, 16-25, 2018
289*2018
Liver metastases from colorectal adenocarcinomas grow in three patterns with different angiogenesis and desmoplasia
PB Vermeulen, C Colpaert, R Salgado, R Royers, H Hellemans, ...
The Journal of Pathology: A Journal of the Pathological Society of Great …, 2001
2752001
Plasma fibrin D-dimer levels correlate with tumour volume, progression rate and survival in patients with metastatic breast cancer
LY Dirix, R Salgado, R Weytjens, C Colpaert, I Benoy, P Huget, ...
British journal of cancer 86 (3), 389-395, 2002
2602002
The system can't perform the operation now. Try again later.
Articles 1–20